Categories
Resources

Current targets and strategies must be corrected to respond adequately to COVID-19 emergency

Statement on Global COVID-19 Summit from ACT-A Civil Society Representatives

Following the Global COVID-19 Summit: Ending the Pandemic and Building Back Better on 22 September, the civil society representatives to ACT-A published a statement, recognising that whilst the the Summit aimed to catalyse and welcome momentum to progress the pandemic response, its targets fall far short in addressing the shortcomings of the current response. We call on the G-7 and G-20 countries to develop more ambitious targets with more urgency with a time bound roadmap and accountability.

The full statement can be found here

Categories
News

Nomination Process: Civil Society and Community Representatives to COVAX Manufacturing Taskforce

The Platform for Civil Society and Community Representatives to ACT-A and the Gavi CSO Steering Committee are currently inviting applications for representatives to the COVAX Manufacturing Taskforce.

The Civil Society & Communities Representatives to the COVAX Manufacturing Taskforce will advocate the viewpoints and needs of NGOs and Communities within the taskforce, working closely with the civil society representatives to COVAX, Gavi CSOs and the Platform for Civil Society and Community Representatives. 

The Platform for Civil Society and Community Representatives to ACT-A and the Gavi CSO Steering Committee are currently inviting applications for five representatives:

  • 1 representative to the manufacturing taskforce leadership team 
  • 1 representative to workstream 1: Improve input supply availability 
  • 1 representative to workstream 2: Maximize mid-term manufacturing capacity
  • 1 representative to workstream 3: New and expanded sustainable capacity in LMICs 
  • 1 representative to workstream 0: Taskforce Coordination Office

How to apply: If you are interested in applying please review the terms of reference which can be found here and submit the following to Courtenay (courtenay@stopaids.org.uk):Completed application form which can be found here

Short CV/resume (maximum 2 pages)

Letter of reference from the NGO to which you are affiliated (if applying as an NGO representative) or from a Community representative or colleague (if applying as a Community representative)

The deadline for applications is 5pm BST on Wednesday 7 July 2021.

If you have any questions or need any further information, please email Courtenay (courtenay@stopaids.org.uk)

Categories
Resources

COVAX Civil Society Representatives – Statement on the launch of the COVAX Investment Opportunity (April 2021)

As the COVAX investment opportunity is launched on Thursday 15 April, the civil society representatives to COVAX have published a statement on the need for a fully funded COVAX to ensure fair and equitable distribution to lifesaving COVID-19 vaccines globally. A copy of the statement can be found here.

Categories
News

Nomination Process: Civil Society Representatives to COVAX AMC Engagement Group and Shareholders Council

The Platform for Civil Society and Community Representatives to ACT-A and the Gavi CSO Steering Committee are currently inviting applications for four representatives, two civil society and community representatives to the AMC Engagement Group and two civil society and community representatives to the Shareholders Council.

The two representatives to the AMC Engagement Group will be joined by a representative from the Gavi CSO Steering Committee and a representative from the COVAX Civil Society Representatives. The two representatives to the Shareholder Council will also be joined by a representative from Gavi CSO Steering Committee and a representative from the COVAX Civil Society Representatives.

The COVAX Facility AMC Engagement Group and Shareholders Council are advisory groups (providing briefings to government) with decisions made at the Gavi Board. Implementers (including civil society) will participate in these meetings as observers. The appointed civil society representatives will work closely with the Gavi CSO Steering Committee, Gavi CSO Board Team and COVAX Civil Society Representatives.

The Civil Society Representatives will:

  • Participate in all meetings of the COVAX AMC Engagement Group or Shareholders Council 
  • Work in collaboration with the Gavi CSO Constituency, COVAX Civil Society Representatives and with the Gavi CSO Board representatives
  • Work in collaboration with other civil society and community representatives across the ACT-A Pillars via the Platform for Civil Society and Community Representatives to ACT-A

How to apply: 

If you are interested in applying please review the terms of reference which can be found here and submit the following to Courtenay (courtenay@stopaids.org.uk):

  • Completed application form which can be found here
  • Short CV/resume (maximum 2 pages)
  • Letter of reference from the NGO to which you are affiliated (if applying as an NGO representative) or from a Community representative or colleague (if applying as a Community representative)

The deadline for applications is 5pm CET on Friday 19 March 2021.

If you have any questions or need any further information, please email Courtenay (courtenay@stopaids.org.uk)

Categories
News

ACT-Accelerator Vaccine Pillar (COVAX) CSO Representatives announced

The ACT-Accelerator (ACT-A) is designed to accelerate the development, production and equitable global access to safe, quality, effective, and affordable COVID-19 diagnostics, therapeutics and vaccines. Developing a vaccine against COVID-19 is one of the most pressing and complex challenge of our time. The global pandemic has already caused the loss of hundreds of thousands of lives and disrupted the lives of billions more. Many leaders have called for a global solution to address a global issue and for a shared endeavour that involves the best shared science to resolve in the shortest possible time a pandemic involving every region and territory on the planet.  

The COVAX Pillar was created by Gavi,CEPI and WHO to act as a platform to support the research, development, manufacturing and delivery of a wide range of COVID-19 vaccine candidates, and to negotiate their pricing, procurement and fair allocation. All participating countries, regardless of income levels, will have equal access to these vaccines once they are developed. The initial aim is to have 2 billion doses available by the end of 2021, which should be enough to protect high risk and vulnerable people, as well as frontline healthcare workers.  

Civil society and community representation and voice is critical across the whole ACT-Accelerator to: to bring their skills and experiences to the collaborative discussions and to ensure a strong independent voice for equity, accountability and to highlight the disproportionate impact and priority needs of affected communities, particularly the poorest and most marginalized.   

In August, the COVAX Pillar lead agencies – Gavi, CEPI and WHO – announced a call for the nomination of 10 civil society and community representatives to be involved across 10 separate working groups within the COVAX Pillar. The selection process was designed and conducted by a civil society Selection Committee, co-chaired by the GAVI CSO Steering Committee and The Platform for ACT-A Civil Society and Community Representatives consisting of committee members from 10 organizations from 7 countries and 4 continents. Applications for the 10 CSO seats came from 159 candidates, over 6 regions. COVAX CSO candidates were selected based on a range of considerations: technical expertise, CSO experience and connectedness, knowledge of immunization and engagement of CSOs in the immunization space, and the detailed technical criteria outlined in the call for applications for each workstream. Diversity in terms of gender and geography was also a consideration. In addition, all candidates were thoroughly assessed by the COVAX workstream leads and leadership.  

The final candidates chosen by the CSO Selection Committee have been agreed by the Covax lead agencies and we are therefore pleased to jointly announce the following CSO representatives for the ACT-Accelerator Vaccine Pillar (COVAX), which will include the 3 workstreams lead by CEPI, WHO and GAVI, including Development & Manufacturing (CEPI led); Access & Allocation, and Vaccine Strategy (WHO led) and Procurement & delivery at Scale (GAVI led):

These civil society and community representatives will work with and be supported by the Gavi CSO Steering Committee and the Platform for ACT-A Civil Society and Community Representatives to consult with broader civil society and connect with civil society and community representatives across the ACT-A.  

Best regards,  

Lisa Hilmi, CORE Group, USA – co-chair (on Behalf of GAVI CSO Steering Committee)
Mike Podmore, STOPAIDS, UK – co-chair (On behalf of Platform for ACT-A Civil Society and Community Representatives)

Platform for ACT-A Civil Society and Community Representatives